Rosiglitazone indications: Difference between revisions

Jump to navigation Jump to search
No edit summary
(No difference)

Revision as of 03:01, 20 December 2011

AVANDIA is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.

  • AVANDIA is indicated as monotherapy.
  • AVANDIA is also indicated for use in combination with a sulfonylurea, metformin, or

insulin when diet, exercise, and a single agent do not result in adequate glycemic control. For patients inadequately controlled with a maximum dose of a sulfonylurea or metformin, AVANDIA should be added to, rather than substituted for, a sulfonylurea or metformin.

  • AVANDIA is also indicated for use in combination with a sulfonylurea plus metformin

when diet, exercise, and both agents do not result in adequate glycemic control.

Management of type 2 diabetes should include diet control. Caloric restriction, weight loss, and exercise are essential for the proper treatment of the diabetic patient because they help improve insulin sensitivity. This is important not only in the primary treatment of type 2